Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer.

@article{Walter2009ProcalcitoninLP,
  title={Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer.},
  author={Martin A. Walter and Christian Meier and Tanja M Radimerski and Fabienne Iten and Marius E. Kraenzlin and Jan Mueller-Brand and Jan Willem B. de Groot and Ido P. Kema and Thera P. Links and Beat P M{\"u}ller},
  journal={Cancer},
  year={2009},
  volume={116 1},
  pages={
          31-40
        }
}
BACKGROUND Procalcitonin has been well established as an important marker of sepsis and systemic infection. The authors evaluated the diagnostic and predictive value of calcitonin and its prohormone procalcitonin in medullary thyroid cancer. METHODS The authors systematically explored the ability of calcitonin and procalcitonin to identify medullary thyroid cancer and predict the endpoints local recurrence and distant metastases, as well as the progression-free survival. Patients with C-cell… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 16 CITATIONS

Procalcitonin for detecting medullary thyroid carcinoma: a systematic review.

VIEW 5 EXCERPTS
CITES METHODS, RESULTS & BACKGROUND
HIGHLY INFLUENCED

Dosages de la calcitonine : indications et interprétation

VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Uso della procalcitonina come marker del carcinoma midollare tiroideo

  • La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND